首页> 外国专利> Composition for photodynamic therapy using gene expressing red fluorescent protein and tin ethyl etiopurpurin and method for photodynamic therapy using thereof

Composition for photodynamic therapy using gene expressing red fluorescent protein and tin ethyl etiopurpurin and method for photodynamic therapy using thereof

机译:使用表达红色荧光蛋白和锡乙基紫嘌呤的基因进行光动力治疗的组合物及其使用的光动力治疗方法

摘要

The present invention relates to a photodynamic treatment composition using tin ethyl etiopurpurin and a red fluorescent protein-expressing gene, and a photodynamic treatment method using the same. Specifically, provided are a photodynamic treatment composition and a photodynamic treatment method using the same. To this end, tin ethyl etiopurpurin is treated as a photosensitizer to cancer cells in which a red fluorescent protein is introduced, and the yellow light is irradiated. According to the present invention, it is possible to selectively kill only the cancer cells into which red fluorescent protein is introduced without affecting normal cells.
机译:本发明涉及使用乙基乙基紫嘌呤和表达红色荧光蛋白的基因的光动力处理组合物,以及使用其的光动力处理方法。具体地,提供了光动力处理组合物和使用其的光动力处理方法。为此,乙基乙基紫嘌呤锡被视为对癌细胞的光敏剂,其中引入了红色荧光蛋白,并照射了黄光。根据本发明,可以仅杀死导入了红色荧光蛋白的癌细胞而不会影响正常细胞。

著录项

  • 公开/公告号KR20180084335A

    专利类型

  • 公开/公告日2018-07-25

    原文格式PDF

  • 申请/专利权人 CORE PHARMA CO. LTD.;

    申请/专利号KR20170007301

  • 发明设计人 MOON GYEONG SOO;

    申请日2017-01-16

  • 分类号A61K41;

  • 国家 KR

  • 入库时间 2022-08-21 12:39:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号